Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiphospholipid Syndrome (APS)”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Looking for participantsNCT03152058
What this trial is testing

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Who this might be right for
High Risk PregnancyPregnancy ComplicationsAntiphospholipid Syndrome in Pregnancy+1 more
David Ware Branch 55
Testing effectiveness (Phase 2)Looking for participantsNCT07584083
What this trial is testing

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)
National and Kapodistrian University of Athens 20
Post-approval studies (Phase 4)Study completedNCT02326051
What this trial is testing

Timing of Initiation of LMWH Administration in Pregnant Women With APS

Who this might be right for
Recurrent MiscarriageAntiphospholipid Syndrome
Mohamed Sayed Abdelhafez 100
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Testing effectiveness (Phase 2)Looking for participantsNCT06747312
What this trial is testing

Effect of Belimumab on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Not applicableStudy completedNCT05195372
What this trial is testing

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeVenous ThromboembolismArterial Thromboembolism+1 more
Cardioangiologisches Centrum Bethanien 80
Early research (Phase 1)Looking for participantsNCT07104721
What this trial is testing

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Systemic Sclerosis (SSc)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)WithdrawnNCT07172022
What this trial is testing

Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)

Who this might be right for
Antiphospholipid Syndrome
Hoffmann-La Roche
Not applicableUnknownNCT05075928
What this trial is testing

Description of a Cohort of Covid-19 Patients With a Circulating Anticoagulant

Who this might be right for
SARS-COV-2
University Hospital, Strasbourg, France 100
Not applicableLooking for participantsNCT04262492
What this trial is testing

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

Who this might be right for
Antiphospholipid SyndromeThrombosisAnticoagulants Causing Adverse Effects in Therapeutic Use
Stéphane Zuily 500
Not applicableLooking for participantsNCT00198068
What this trial is testing

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

Who this might be right for
Systemic Lupus ErythematosusAntiphospholipid Syndrome
Hospital for Special Surgery, New York 700
Not applicableActive Not RecruitingNCT01787305
What this trial is testing

Pilot Study of Gut Commensals in Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome (APS)
Yale University 16
Not applicableNot Yet RecruitingNCT06929182
What this trial is testing

OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs

Who this might be right for
Antiphospholipid Syndrome (APS)Direct Oral Anticoagulants (DOACs)Thrombotic and Bleeding Events+1 more
Central Hospital, Nancy, France 500
Not applicableLooking for participantsNCT07372170
What this trial is testing

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)Venous Thrombosis (Disorder)Thrombophilia
Infanta Leonor University Hospital 600
Not applicableUnknownNCT01956188
What this trial is testing

Omega 3 in LES and APS

Who this might be right for
Systemic Lupus ErythematosusPrimary Antiphospholipid Syndrome
University of Sao Paulo 22
Not applicableLooking for participantsNCT05646394
What this trial is testing

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Who this might be right for
Antiphospholipid SyndromeArterial Thrombosis
McMaster University 150
Not applicableLooking for participantsNCT05904301
What this trial is testing

Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases

Who this might be right for
Behcet DiseaseAntineutrophil Cytoplasmic Antibody (ANCA) Positive VasculitisTakayasu Arteritis+6 more
Santé Arménie French-Armenian Research Center 800
Testing effectiveness (Phase 2)Ended earlyNCT05078710
What this trial is testing

Telitacicept in Primary APS Patients

Who this might be right for
Anti Phospholipid Syndrome
Peking Union Medical College Hospital 20
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT02128269
What this trial is testing

Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid (aPL)-Positive
Alexion Pharmaceuticals, Inc. 9
Load More Results